Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Reduced mortality after allogeneic hematopoietic-cell transplantation.

Gooley TA, Chien JW, Pergam SA, Hingorani S, Sorror ML, Boeckh M, Martin PJ, Sandmaier BM, Marr KA, Appelbaum FR, Storb R, McDonald GB.

N Engl J Med. 2010 Nov 25;363(22):2091-101. doi: 10.1056/NEJMoa1004383.

2.

Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.

Martin PJ, Counts GW Jr, Appelbaum FR, Lee SJ, Sanders JE, Deeg HJ, Flowers ME, Syrjala KL, Hansen JA, Storb RF, Storer BE.

J Clin Oncol. 2010 Feb 20;28(6):1011-6. doi: 10.1200/JCO.2009.25.6693. Epub 2010 Jan 11.

3.

High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study.

Bresters D, van Gils IC, Kollen WJ, Ball LM, Oostdijk W, van der Bom JG, Egeler RM.

Bone Marrow Transplant. 2010 Jan;45(1):79-85. doi: 10.1038/bmt.2009.92. Epub 2009 May 4.

PMID:
19421172
4.

Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.

Mertens AC, Liu Q, Neglia JP, Wasilewski K, Leisenring W, Armstrong GT, Robison LL, Yasui Y.

J Natl Cancer Inst. 2008 Oct 1;100(19):1368-79. doi: 10.1093/jnci/djn310. Epub 2008 Sep 23.

5.

Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study.

Bhatia S, Francisco L, Carter A, Sun CL, Baker KS, Gurney JG, McGlave PB, Nademanee A, O'Donnell M, Ramsay NK, Robison LL, Snyder D, Stein A, Forman SJ, Weisdorf DJ.

Blood. 2007 Nov 15;110(10):3784-92. Epub 2007 Aug 1.

6.

Medical assessment of adverse health outcomes in long-term survivors of childhood cancer.

Geenen MM, Cardous-Ubbink MC, Kremer LC, van den Bos C, van der Pal HJ, Heinen RC, Jaspers MW, Koning CC, Oldenburger F, Langeveld NE, Hart AA, Bakker PJ, Caron HN, van Leeuwen FE.

JAMA. 2007 Jun 27;297(24):2705-15.

PMID:
17595271
7.

Long-term outcomes after allogeneic stem cell transplantation for children with hematological malignancies.

Ferry C, Gemayel G, Rocha V, Labopin M, Esperou H, Robin M, de Latour RP, Ribaud P, Devergie A, Leblanc T, Gluckman E, Baruchel A, SociƩ G.

Bone Marrow Transplant. 2007 Aug;40(3):219-24. Epub 2007 May 28.

PMID:
17530002
8.

Long-term follow-up of children who underwent hematopoeitic cell transplant (HCT) for AML or ALL at less than 3 years of age.

Perkins JL, Kunin-Batson AS, Youngren NM, Ness KK, Ulrich KJ, Hansen MJ, Petryk A, Steinberger J, Anderson FS, Baker KS.

Pediatr Blood Cancer. 2007 Dec;49(7):958-63.

PMID:
17474113
9.

Chronic health conditions in adult survivors of childhood cancer.

Oeffinger KC, Mertens AC, Sklar CA, Kawashima T, Hudson MM, Meadows AT, Friedman DL, Marina N, Hobbie W, Kadan-Lottick NS, Schwartz CL, Leisenring W, Robison LL; Childhood Cancer Survivor Study.

N Engl J Med. 2006 Oct 12;355(15):1572-82.

10.

Very late nonfatal consequences of fractionated TBI in children undergoing bone marrow transplant.

Faraci M, Barra S, Cohen A, Lanino E, Grisolia F, Miano M, Foppiano F, Sacco O, Cabria M, De Marco R, Stella G, Dallorso S, Bagnasco F, Vitale V, Dini G, Haupt R.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1568-75. Epub 2005 Jun 28.

PMID:
15990246
11.

Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study.

Bhatia S, Robison LL, Francisco L, Carter A, Liu Y, Grant M, Baker KS, Fung H, Gurney JG, McGlave PB, Nademanee A, Ramsay NK, Stein A, Weisdorf DJ, Forman SJ.

Blood. 2005 Jun 1;105(11):4215-22. Epub 2005 Feb 8.

12.

Late effects of chemotherapy compared to bone marrow transplantation in the treatment of pediatric acute myeloid leukemia and myelodysplasia.

Leahey AM, Teunissen H, Friedman DL, Moshang T, Lange BJ, Meadows AT.

Med Pediatr Oncol. 1999 Mar;32(3):163-9.

PMID:
10064182

Supplemental Content

Support Center